Abatacept reduces fatigue and pain severity and sleep problems through 2 years in rheumatoid arthritis patients in the AIM and ATTAIN trials

Category Primary study
JournalJournal of Rheumatology
Year 2008

This article is included in 1 Systematic review Systematic reviews (1 reference)

This article is part of the following publication threads:
  • ATTAIN [Abatacept Trial in Treatment of Anti-TNF INadequate responders] (15 documents)
Loading references information
This article has no abstract
Epistemonikos ID: 16709b2c19f0e98187e84bb0e6f55e9ca1dc4a4f
First added on: Oct 21, 2017